Susquehanna International Group
EBS icon

Susquehanna International Group’s Emergent Biosolutions EBS Stock Holding History

Susquehanna International Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Buy
52,500
+14,700
+39% +$152K ﹤0.01% 10010
2025
Q4 		$467K Sell
37,800
-37,200
-50% -$399K ﹤0.01% 8943
2025
Q3 		$662K Buy
75,000
+37,900
+102% +$295K ﹤0.01% 8342
2025
Q2 		$237K Sell
37,100
-18,400
-33% -$105K ﹤0.01% 10880
2025
Q1 		$270K Sell
55,500
-8,600
-13% -$71.2K ﹤0.01% 10296
2024
Q4 		$613K Sell
64,100
-177,600
-73% -$1.63M ﹤0.01% 8178
2024
Q3 		$2.02M Buy
241,700
+176,000
+268% +$1.6M ﹤0.01% 5239
2024
Q2 		$448K Buy
65,700
+52,900
+413% +$228K ﹤0.01% 8530
2024
Q1 		$32.4K Buy
+12,800
New +$28.9K ﹤0.01% 11693
2023
Q3 		– Sell
-26,200
Closed -$193K – 12215
2023
Q2 		$193K Buy
26,200
+11,200
+75% +$104K ﹤0.01% 10311
2023
Q1 		$155K Buy
15,000
+1,100
+8% +$13.3K ﹤0.01% 10879
2022
Q4 		$164K Buy
+13,900
New +$215K ﹤0.01% 10390
2022
Q3 		– Sell
-8,500
Closed -$264K – 13371
2022
Q2 		$264K Sell
8,500
-2,900
-25% -$99K ﹤0.01% 9901
2022
Q1 		$468K Sell
11,400
-9,700
-46% -$428K ﹤0.01% 9164
2021
Q4 		$917K Sell
21,100
-3,000
-12% -$136K ﹤0.01% 7533
2021
Q3 		$1.21M Sell
24,100
-56,400
-70% -$3.42M ﹤0.01% 7058
2021
Q2 		$5.07M Buy
80,500
+24,100
+43% +$1.55M ﹤0.01% 4018
2021
Q1 		$5.24M Sell
56,400
-56,700
-50% -$5.81M ﹤0.01% 3828
2020
Q4 		$10.1M Buy
113,100
+85,500
+310% +$7.85M ﹤0.01% 2481
2020
Q3 		$2.85M Sell
27,600
-13,600
-33% -$1.47M ﹤0.01% 3960
2020
Q2 		$3.26M Buy
41,200
+15,100
+58% +$1.13M ﹤0.01% 3660
2020
Q1 		$1.51M Sell
26,100
-18,900
-42% -$1.09M ﹤0.01% 4484
2019
Q4 		$2.43M Buy
45,000
+2,700
+6% +$146K ﹤0.01% 4009
2019
Q3 		$2.21M Buy
+42,300
New +$1.97M ﹤0.01% 4000
2019
Q2 		– Sell
-10,900
Closed -$551K – 10324
2019
Q1 		$551K Buy
+10,900
New +$643K ﹤0.01% 6075
2018
Q3 		– Sell
-6,900
Closed -$348K – 9423
2018
Q2 		$348K Buy
+6,900
New +$360K ﹤0.01% 7542
2018
Q1 		– Sell
-13,700
Closed -$637K – 9468
2017
Q4 		$637K Buy
+13,700
New +$577K ﹤0.01% 6151
2017
Q3 		– Sell
-6,200
Closed -$210K – 8971
2017
Q2 		$210K Sell
6,200
-6,200
-50% -$191K ﹤0.01% 8205
2017
Q1 		$360K Sell
12,400
-400
-3% -$12.2K ﹤0.01% 7061
2016
Q4 		$420K Buy
12,800
+2,000
+19% +$60K ﹤0.01% 7340
2016
Q3 		$341K Sell
10,800
-79,100
-88% -$2.3M ﹤0.01% 6720
2016
Q2 		$2.53M Sell
89,900
-6,200
-6% -$243K ﹤0.01% 3183
2016
Q1 		$3.49M Buy
+96,100
New +$3.39M ﹤0.01% 2817

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Susquehanna International Group's EBS Position: Q1 2026 in Review

Susquehanna International Group reduced its Emergent Biosolutions (EBS) stake by 87% in Q1 2026, selling an estimated $3.41M and leaving 48,439 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #10199.

Susquehanna International Group first reported a position in EBS in Q1 2014 and has held it in 35 quarters since. The position peaked at $13.7M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Susquehanna International Group held 48,439 shares of Emergent Biosolutions worth $402K as of Q1 2026.
  • Susquehanna International Group sold 329,273 Emergent Biosolutions shares in Q1 2026, an estimated $3.41M.
  • Emergent Biosolutions made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10199 holding.
  • Susquehanna International Group first reported a position in Emergent Biosolutions in Q1 2014 and has held it in 35 quarters since.
  • Susquehanna International Group's Emergent Biosolutions position peaked at $13.7M in Q3 2020.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.